HealthCareMagic is now Ask A Doctor - 24x7 | https://www.askadoctor24x7.com

question-icon

Can Opdivo Infusion Be Administered As An Intravenous Push For The Treatment Of Leptomeningeal Melanoma?

default
Posted on Thu, 27 Jul 2023
Question: My brother has had stage 4 metastatic melanoma for 2 years. He was just diagnosed with leptomeningial disease 2 weeks ago and is on steroids and radiation. He has had one dose of Opdivo, delivered through a port, but not interethically. The docs decided against interethical treatment and I don’t know why. Does this mean there is no hope?
doctor
Answered by Dr. Lekshmi Rita Venugopal (2 hours later)
Brief Answer:
Intrathecal administration of Opdivo is in early research phases only

Detailed Answer:

Hello,

Opdivo is currently used as an intravenous medication for the treatment of leptomeningeal melanoma. Such mode of administration has been found helpful in prolonging over all survival rate. Intrathecal administration of Opdivo is only in early research (clinical trial) phase. So not enough data is available in that regard. That must be likely why the doctors have decided against intrathecal administration.

Hope this answers your question.

Regards,
Dr. Lekshmi Rita Venugopal, General & Family Physician
Note: For further queries related to kidney problems Click here.

Above answer was peer-reviewed by : Dr. Kampana
doctor
Answered by
Dr.
Dr. Lekshmi Rita Venugopal

General & Family Physician

Practicing since :2012

Answered : 3808 Questions

premium_optimized

The User accepted the expert's answer

Share on

Get personalised answers from verified doctor in minutes across 80+ specialties

159 Doctors Online

By proceeding, I accept the Terms and Conditions

HCM Blog Instant Access to Doctors
HCM Blog Questions Answered
HCM Blog Satisfaction
Can Opdivo Infusion Be Administered As An Intravenous Push For The Treatment Of Leptomeningeal Melanoma?

Brief Answer: Intrathecal administration of Opdivo is in early research phases only Detailed Answer: Hello, Opdivo is currently used as an intravenous medication for the treatment of leptomeningeal melanoma. Such mode of administration has been found helpful in prolonging over all survival rate. Intrathecal administration of Opdivo is only in early research (clinical trial) phase. So not enough data is available in that regard. That must be likely why the doctors have decided against intrathecal administration. Hope this answers your question. Regards, Dr. Lekshmi Rita Venugopal, General & Family Physician